Variable

Category

N

Frequency %

Mean

Missing

Age

Study Group

Cohort Group

Study Group

Cohort Group

Study Group

Cohort Group

Study Group

Cohort Group

60.4

62.1

0

0

<55 years

19

12

35.8

33.3

56 - 65 years

18

12

34.0

33.3

66 - 75 years

7

7

13.2

19.4

76 - 85 years

7

1

13.2

2.8

≥86 years

2

4

3.8

11.1

Gender

--

--

0

0

Male

27

20

50.9

55.6

Female

26

16

49.1

44.4

Initial Systolic BP

206.5

185.9

0

0

Stage 1 Hypertension (SBP ≤ 140)

4

2

7.5

5.6

Stage 2 Hypertension (SBP 141 - 160)

4

8

7.5

22.2

Stage 3 Hypertension (SBP 161 - 180)

4

3

7.5

8.3

Stage 4 Hypertension (SBP 181 - 210)

13

14

24.5

38.9

Exceeds Stage 4 Hypertension

28

9

52.8

25.0

Initial Diastolic BP

120.4

96.0

0

0

Stage 1 Hypertension (DBP ≤ 90)

4

18

7.5

50.0

Stage 2 Hypertension (SBP 91 - 100)

9

4

17

11.1

Stage 3 Hypertension (SBP 101 - 110)

9

5

17

13.9

Stage 4 Hypertension (SBP 111 - 120)

6

4

11.3

11.1

Exceeds Stage 4 Hypertension

25

5

47.2

13.9

Controlled BP

--

--

0

7

Yes

52

28

98.1

77.8

No

1

1

1.9

2.8

Time to first dose of Cardene

51.8

84.7

1

0

No Cardene given

0

9

0

25.0

1 - 60 minutes

36

8

67.9

22.2

61 - 360 minutes

16

18

30.2

50.0

Time to control BP

175.4

91.4

0

1

BP control not reached

0

1

0

2.8

1 - 60 minutes

7

8

13.2

22.2

61 - 360 minutes

42

18

79.2

50.0